サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1661011

人工膵臓デバイスシステム市場レポート：デバイスタイプ別、治療タイプ別、エンドユーザー別、地域別、2025年～2033年

Artificial Pancreas Device Systems Market Report by Device Type, Treatment Type, End-User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 142 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
人工膵臓デバイスシステム市場レポート：デバイスタイプ別、治療タイプ別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年02月10日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の人工膵臓デバイスシステム（APDS）の市場規模は2024年に25億7,940万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに60億2,720万米ドルに達し、2025年から2033年にかけて9.9%の成長率（CAGR）を示すと予測しています。

APDSは、インスリンの分泌を調節することで血糖値を管理するクローズドループまたは自動インスリン分泌システムを指します。連続グルコースモニター（CGM）、皮下インスリン注入ポンプ、モニターとポンプをつなぐコントローラーで構成されます。リアルタイムのグルコース測定値の評価に基づいて、インスリンの適切なレベルと投与時間を決定する複雑なアルゴリズムを実行します。主に、体内のグルコースレベルが極端に変動するリスクを最小限に抑えるために使用されます。

膵臓がん、膵炎、その他の慢性疾患の有病率の増加は、市場の成長を促進する主な要因の1つです。さらに、加齢関連要因、運動不足、不健康な食事パターンによる糖尿病や肥満の発生が増加していることも、世界中でAPDSが広く採用される要因となっています。効率的な糖尿病モニタリングや低侵襲（MI）ドラッグデリバリーシステムに対する需要の高まりも、市場成長に弾みをつけています。APDSは自動的にグルコースレベルを監視し、制御された量のインスリンを一日中投与します。自動制御と統合されたソフトウェアベースの無線システムの開発など、さまざまな技術革新がさらに市場成長に貢献しています。さらに、各国の規制機関や政府は、世界中のヘルスケア・インフラを改善するための研究開発（R&D）に多額の投資を行っています。例えば、米国の食品医薬品協会（US FDA）は、革新的な新製品をどんどん承認しており、同国の市場に明るい見通しをもたらしています。

本レポートで扱う主な質問

  • 人工膵臓デバイスシステム市場の世界市場はこれまでどのように推移してきたか？
  • 主要な地域市場は？
  • COVID-19は世界の人工膵臓デバイスシステム市場にどのような影響を与えたか？
  • デバイスタイプ別の市場内訳は？
  • 治療タイプ別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 世界の人工膵臓デバイスシステム市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の人工膵臓デバイスシステム市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：デバイスタイプ別

  • スレッショルドサスペンデッドデバイスシステム
    • 市場動向
    • 市場予測
  • Control-to-Rangeシステム
    • 市場動向
    • 市場予測
  • Control-to-Targetシステム
    • 市場動向
    • 市場予測

第7章 市場内訳：治療タイプ別

  • バイホルモン
    • 市場動向
    • 市場予測
  • インスリンのみ
    • 市場動向
    • 市場予測
  • ハイブリッド
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 医療センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格指標

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Beta Bionics Inc.
    • Bigfoot Biomedical Inc.
    • Dexcom Inc.
    • Inreda Diabetic B.V.
    • Insulet Corporation
    • Johnson & Johnson
    • Medtronic Inc.
    • F. Hoffmann-La Roche Ltd
    • Tandem Diabetes Care Inc.
図表

List of Figures

  • Figure 1: Global: Artificial Pancreas Device Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Artificial Pancreas Device Systems Market: Breakup by Device Type (in %), 2024
  • Figure 4: Global: Artificial Pancreas Device Systems Market: Breakup by Treatment Type (in %), 2024
  • Figure 5: Global: Artificial Pancreas Device Systems Market: Breakup by End-User (in %), 2024
  • Figure 6: Global: Artificial Pancreas Device Systems Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 8: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Artificial Pancreas Device Systems (Control-to-Range Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Artificial Pancreas Device Systems (Control-to-Range Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Artificial Pancreas Device Systems (Insulin Only) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Artificial Pancreas Device Systems (Insulin Only) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Artificial Pancreas Device Systems (Hybrid) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Artificial Pancreas Device Systems (Hybrid) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Artificial Pancreas Device Systems (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Artificial Pancreas Device Systems (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Artificial Pancreas Device Systems (Medical Centres) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Artificial Pancreas Device Systems (Medical Centres) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Artificial Pancreas Device Systems (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Artificial Pancreas Device Systems (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia Pacific: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia Pacific: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Artificial Pancreas Device Systems Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Global: Artificial Pancreas Device Systems Industry: SWOT Analysis
  • Figure 75: Global: Artificial Pancreas Device Systems Industry: Value Chain Analysis
  • Figure 76: Global: Artificial Pancreas Device Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Pancreas Device Systems Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Device Type (in Million USD), 2025-2033
  • Table 3: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 4: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by End-User (in Million USD), 2025-2033
  • Table 5: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Artificial Pancreas Device Systems Market: Competitive Structure
  • Table 7: Global: Artificial Pancreas Device Systems Market: Key Players
目次
Product Code: SR112025A1918

The global artificial pancreas device systems (APDS) market size reached USD 2,579.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 6,027.2 Million by 2033, exhibiting a growth rate (CAGR) of 9.9% during 2025-2033.

APDS refers to a closed-loop or automated insulin delivery system that manages blood glucose levels by regulating the production of insulin. It consists of a continuous glucose monitor (CGM), a subcutaneous insulin infusion pump and a controller that links the monitor with the pump. It runs a complex algorithm that determines the adequate levels of insulin and time of delivery based on the evaluation of real-time glucose readings. It is primarily used to minimize the risks of extreme fluctuations of glucose levels in the body.

The increasing prevalence of pancreatic cancer, pancreatitis and other chronic ailments is one of the key factors driving the growth of the market. Furthermore, the growing occurrence of diabetes and obesity, due to age-related factors, physical inactivity and unhealthy dietary patterns, is also contributing to the widespread adoption of APDS across the globe. The rising demand for efficient diabetes monitoring and minimally invasive (MI) drug delivery systems is also providing a boost to the market growth. APDS automatically monitors the glucose levels and administers doses of insulin throughout the day in controlled amounts. Various technological innovations, including the development of software-based wireless systems that are integrated with automated controls, are further contributing to the market growth. Moreover, regulatory bodies and governments of various nations are significantly investing in research and development (R&D) for the improvement of healthcare infrastructure across the globe. For instance, the Food and Drug Association (US FDA) in the United States is approving an increasing number of new and innovative products, which is creating a positive outlook for the market in the country.

Key Market Segmentation:

Breakup by Device Type:

  • Threshold Suspend Device Systems
  • Control-to-Range Systems
  • Control-to-Target Systems

Breakup by Treatment Type:

  • Bi-hormonal
  • Insulin Only
  • Hybrid

Breakup by End-User:

  • Hospitals
  • Medical Centres
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Beta Bionics Inc., Bigfoot Biomedical Inc., Dexcom Inc., Inreda Diabetic B.V., Insulet Corporation, Johnson & Johnson, Medtronic Inc., F. Hoffmann-La Roche Ltd, Tandem Diabetes Care Inc., etc.

Key Questions Answered in This Report:

  • How has the global artificial pancreas device systems market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global artificial pancreas device systems market?
  • What is the breakup of the market based on the device type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global artificial pancreas device systems market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Pancreas Device Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device Type

  • 6.1 Threshold Suspend Device Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Control-to-Range Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Control-to-Target Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Bi-hormonal
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Insulin Only
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hybrid
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Medical Centres
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Beta Bionics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bigfoot Biomedical Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Dexcom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Inreda Diabetic B.V.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Insulet Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 F. Hoffmann-La Roche Ltd
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Tandem Diabetes Care Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials